EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,874,375 | -18.9% | 118,857 | 0.0% | 0.26% | -22.4% |
| Q2 2023 | $2,310,580 | +1.8% | 118,857 | +48.6% | 0.34% | +0.6% |
| Q1 2023 | $2,269,600 | -34.7% | 80,000 | -32.7% | 0.34% | -33.1% |
| Q4 2022 | $3,474,190 | +10.6% | 118,857 | 0.0% | 0.50% | +31.2% |
| Q3 2022 | $3,140,000 | +18.7% | 118,857 | +90.9% | 0.38% | -19.6% |
| Q3 2020 | $2,645,000 | -78.4% | 62,262 | -75.6% | 0.48% | -59.8% |
| Q2 2020 | $12,264,000 | +4.3% | 255,616 | 0.0% | 1.19% | -27.8% |
| Q1 2020 | $11,758,000 | – | 255,616 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |